Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 5Breast 5Thoracic 3Head & Neck 3Genitourinary 3Sarcoma 1Other solid neoplasm 1Lymphoid 1Gynecologic 1Dermatologic 1CNS 1

Conditions

Sarcoma 1571Glioblastoma 512Gliosarcoma 485Osteosarcoma 458Brain Neoplasms 344Gastrointestinal Stromal Tumors 326Central Nervous System Neoplasms 296Neoplasms 291Dendritic Cell Sarcoma, Interdigitating 286Astrocytoma 275Lymphoma 259Bone Neoplasms 245Breast Neoplasms 238Sarcoma, Ewing 237Glioma 236Neuroblastoma 230Rhabdomyosarcoma 226Melanoma 224Precursor Cell Lymphoblastic Leukemia-Lymphoma 218Recurrence 216Lymphoma, Non-Hodgkin 216Burkitt Lymphoma 213Oligodendroglioma 203Ovarian Neoplasms 202Lymphoma, Large B-Cell, Diffuse 187Neoplasm Metastasis 186Lymphoma, Follicular 172Leukemia 164Leukemia, Lymphocytic, Chronic, B-Cell 158Hodgkin Disease 158

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Camurati-Engelmann Syndrome × Sarcoma × Clear all
NCT00686738 2016-03-23

Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients

National Cancer Center, Korea

Completed
20 enrolled
Sarcoma

Camurati-Engelmann Syndrome, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡